Accessibility Menu
Willow Biosciences logo

Willow Biosciences

(TSX) WLLW

Current PriceN/A
Market CapN/A
Since IPO (2019)-99%
5 Year-97%
1 Year-11%
1 Month-11%

Willow Biosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$5.34M

Net Income (TTM)

-CA$2.09M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 11, 2025

WLLW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Willow Biosciences

Industry

Biotechnology

Employees

16

CEO

Mark Hodgson

Headquarters

Calgary, AB T2R 0Y6, CA

WLLW Financials

Key Financial Metrics (TTM)

Gross Margin

1%

Operating Margin

-64%

Net Income Margin

-23%

Return on Equity

-9%

Return on Capital

-8%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

CA$3.28M

Operating Income

-CA$5.99M

EBITDA

-CA$4.54M

Operating Cash Flow

-CA$3.72M

Capital Expenditure

-CA$20.00K

Free Cash Flow

-CA$3.74M

Cash & ST Invst.

CA$353.00K

Total Debt

CA$1.97M

Willow Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

CA$0.00

-100.0%

Gross Profit

CA$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

19

N/A

Net Income

CA$370.00K

+121.9%

EBITDA

-CA$891.00K

+18.8%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

CA$29.22M

+3473.7%

Accounts Receivable

CA$86.00K

+561.5%

Inventory

CA$0.00

-100.0%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-2.85%

N/A

Return on Invested Capital

-8.13%

N/A

Free Cash Flow

-CA$1.88M

-156.5%

Operating Cash Flow

-CA$1.88M

-156.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,433.37+0.01%
^DJIDJI
$50,912.34+0.00%
^IXICNASDAQ
$26,036.82+0.01%
BTCBitcoin
$63,510.00+0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
SUNESUNation Energy
$5.88+4.20%
INHDInno
$39.49+36.61%
AALAmerican Airlines Group
$13.60+0.01%
NOKNokia
$14.59+0.01%

Questions About WLLW

What is the current price of Willow Biosciences?

Willow Biosciences is trading at N/A per share.

What is the 52-week range for Willow Biosciences?

Over the past 52 weeks, Willow Biosciences has traded between N/A and N/A.

How much debt does Willow Biosciences have?

As of the most recent reporting period, Willow Biosciences reported total debt of CA$0.00.

How much cash does Willow Biosciences have on hand?

Willow Biosciences reported CA$26.68M in cash and cash equivalents in its most recent financial results.

What is Willow Biosciences’s dividend yield?

Willow Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.